Stevanato Group S.p.A. (NYSE:STVN) Stock Holdings Increased by First Bank & Trust

First Bank & Trust lifted its stake in Stevanato Group S.p.A. (NYSE:STVN) by 7.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 15,145 shares of the company’s stock after purchasing an additional 1,036 shares during the quarter. First Bank & Trust’s holdings in Stevanato Group were worth $330,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Hardy Reed LLC raised its position in Stevanato Group by 8.2% during the third quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock valued at $222,000 after acquiring an additional 840 shares in the last quarter. Lindenwold Advisors INC raised its position in Stevanato Group by 13.5% during the third quarter. Lindenwold Advisors INC now owns 11,930 shares of the company’s stock valued at $239,000 after acquiring an additional 1,415 shares in the last quarter. Raymond James Trust N.A. raised its position in Stevanato Group by 22.6% during the third quarter. Raymond James Trust N.A. now owns 12,556 shares of the company’s stock valued at $251,000 after acquiring an additional 2,317 shares in the last quarter. Captrust Financial Advisors raised its position in Stevanato Group by 12.7% during the third quarter. Captrust Financial Advisors now owns 13,100 shares of the company’s stock valued at $262,000 after acquiring an additional 1,480 shares in the last quarter. Finally, SG Americas Securities LLC raised its position in Stevanato Group by 18.2% during the fourth quarter. SG Americas Securities LLC now owns 15,546 shares of the company’s stock valued at $339,000 after acquiring an additional 2,389 shares in the last quarter.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Morgan Stanley reaffirmed an “equal weight” rating and set a $23.00 price objective (down previously from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. Bank of America raised their price objective on shares of Stevanato Group from $24.00 to $26.00 and gave the company a “buy” rating in a research report on Friday, December 13th. Finally, Wolfe Research started coverage on Stevanato Group in a report on Friday, December 13th. They set an “outperform” rating and a $28.00 price target on the stock. One analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of €28.60 ($30.11).

Stevanato Group Trading Down 0.2 %

Shares of STVN stock opened at €20.31 ($21.38) on Friday. Stevanato Group S.p.A. has a 12 month low of €16.56 ($17.43) and a 12 month high of €34.00 ($35.79). The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The business’s 50 day moving average is €21.82 and its two-hundred day moving average is €20.53. The company has a market cap of $6.15 billion, a PE ratio of 43.21, a price-to-earnings-growth ratio of 7.07 and a beta of 0.56.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.